Spanish international pharmaceutical company Ferrer has announced the completion of patient recruitment for the PROSPER study, a Phase II clinical trial designed to assess the efficacy, safety, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback